Inhibition of N-type calcium channels by activation of GPR35, an orphan receptor, heterologously expressed in rat sympathetic neurons
- PMID: 17940199
- DOI: 10.1124/jpet.107.127266
Inhibition of N-type calcium channels by activation of GPR35, an orphan receptor, heterologously expressed in rat sympathetic neurons
Abstract
GPR35 is a G protein-coupled receptor recently "de-orphanized" using high-throughput intracellular calcium measurements in clonal cell lines expressing a chimeric G-protein alpha-subunit. From these screens, kynurenic acid, an endogenous metabolite of tryptophan, and zaprinast, a synthetic inhibitor of cyclic guanosine monophosphate-specific phosphodiesterase, emerged as potential agonists for GPR35. To investigate the coupling of GPR35 to natively expressed neuronal signaling pathways and effectors, we heterologously expressed GPR35 in rat sympathetic neurons and examined the modulation of N-type (Ca(V)2.2) calcium channels. In neurons expressing GPR35, calcium channels were inhibited in the absence of overt agonists, indicating a tonic receptor activity. Application of kynurenic acid or zaprinast resulted in robust voltage-dependent calcium current inhibition characteristic of Gbetagamma-mediated modulation. Both agonist-independent and -dependent effects of GPR35 were blocked by Bordetella pertussis toxin pretreatment indicating the involvement of G(i/o) proteins. In neurons expressing GPR35a, a short splice variant of GPR35, zaprinast was more potent (EC(50) = 1 microM) than kynurenic acid (58 microM) but had a similar efficacy (approximately 60% maximal calcium current inhibition). Expression of GPR35b, which has an additional 31 residues at the N terminus, produced similar results but with much greater variability. Both GPR35a and GPR35b appeared to have similar expression patterns when fused to fluorescent proteins. These results suggest a potential role for GPR35 in regulating neuronal excitability and synaptic release.
Similar articles
-
Kynurenic acid and zaprinast induce analgesia by modulating HCN channels through GPR35 activation.Neuropharmacology. 2016 Sep;108:136-43. doi: 10.1016/j.neuropharm.2016.04.038. Epub 2016 Apr 27. Neuropharmacology. 2016. PMID: 27131920
-
Phosducin and phosducin-like protein attenuate G-protein-coupled receptor-mediated inhibition of voltage-gated calcium channels in rat sympathetic neurons.Mol Pharmacol. 2006 Jul;70(1):90-100. doi: 10.1124/mol.105.021394. Epub 2006 Apr 11. Mol Pharmacol. 2006. PMID: 16608918
-
Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35.FEBS Lett. 2006 Sep 18;580(21):5003-8. doi: 10.1016/j.febslet.2006.08.015. Epub 2006 Aug 17. FEBS Lett. 2006. PMID: 16934253
-
Use of RGS-insensitive Galpha subunits to study endogenous RGS protein action on G-protein modulation of N-type calcium channels in sympathetic neurons.Methods Enzymol. 2004;389:170-89. doi: 10.1016/S0076-6879(04)89011-6. Methods Enzymol. 2004. PMID: 15313566 Review.
-
The emerging pharmacology and function of GPR35 in the nervous system.Neuropharmacology. 2017 Feb;113(Pt B):661-671. doi: 10.1016/j.neuropharm.2015.07.035. Epub 2015 Jul 29. Neuropharmacology. 2017. PMID: 26232640 Review.
Cited by
-
Understanding the kynurenine pathway: A narrative review on its impact across chronic pain conditions.Mol Pain. 2024 Jan-Dec;20:17448069241275097. doi: 10.1177/17448069241275097. Mol Pain. 2024. PMID: 39093627 Free PMC article. Review.
-
Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword?CNS Neurosci Ther. 2022 Jan;28(1):19-35. doi: 10.1111/cns.13768. Epub 2021 Dec 3. CNS Neurosci Ther. 2022. PMID: 34862742 Free PMC article. Review.
-
High-throughput identification and characterization of novel, species-selective GPR35 agonists.J Pharmacol Exp Ther. 2013 Mar;344(3):568-78. doi: 10.1124/jpet.112.201798. Epub 2012 Dec 21. J Pharmacol Exp Ther. 2013. PMID: 23262279 Free PMC article.
-
N-arachidonoyl L-serine, a putative endocannabinoid, alters the activation of N-type Ca2+ channels in sympathetic neurons.J Neurophysiol. 2008 Aug;100(2):1147-51. doi: 10.1152/jn.01204.2007. Epub 2008 Jan 30. J Neurophysiol. 2008. PMID: 18234973 Free PMC article.
-
G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease.Front Pharmacol. 2015 Mar 10;6:41. doi: 10.3389/fphar.2015.00041. eCollection 2015. Front Pharmacol. 2015. PMID: 25805994 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases